Skip to content

Study · In vitro (cells) · rattus norvegicus · 2005

1 result

Rattus norvegicus melanocortin 3 receptor: a corrected sequence.

Daniels D, Suzuki A, Shapiro E, Luo L, Yee DK, Fluharty SJ

Peptides1 Oct 2005Cited by 2 (Europe PMC)

PMID15985309 (opens in a new tab)DOI10.1016/j.peptides.2004.11.032 (opens in a new tab)PepBankPUB-15985309
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Activity measurement

    In cells transiently expressing rat MC3R, the synthetic agonist MTII produced a concentration-dependent cAMP response.

    In plain wordsIn lab cells carrying the rat MC3 receptor, MTII raised cAMP in step with its concentration.

    Peptide
    Melanotan II
    Outcome
    IncreasecAMP response to MTII at rat MC3R
    Study

    Rattus norvegicusn: not reported in source

    transiently expressed rat MC3R
    Outcome group
    Receptor activity and mechanism · Pharmacology
    Studied dose
    Dose not stated

    Source sentences

    Summary
    a concentration-dependent cAMP response to the synthetic agonist MTII.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.